Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor

Overview of attention for article published in Cell Death & Disease, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 3 X users
patent: 4 patents

wikipedia: 1 Wikipedia page

Readers on

mendeley: 86 Mendeley

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 3,101 followers.

Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. https://t.co/PBWxdvo7mm

Open Access UCL Research: Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor - UCL Discovery https://t.co/kY2Vf1Ebs3

Open Access UCL Research: Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor - UCL Discovery https://t.co/kY2Vf1VMjB

Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor | Cell Death & Disease https://t.co/gPz9EtRDU6

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.